Klemt-Pharmasp. z o.o.

Non-specialised wholesale trade

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-06-25
Share capital
50,000.00 PLN
Activity description

Klemt-Pharma has worked for over 30 years with manufacturers of pharmaceuticals, dietary supplements and beverages, and cosmetics. Its products include extracts, supplements and food additives, pharmaceutical and veterinary ingredients, feed additives, oils and waxes, and disposable protective clothing.

Registered address
ul. Kazimierza Wóycickiego 7E/2, 01-938 Warszawa, Poland
Phone
Electronic delivery address
AE:PL-29649-93872-IWAGT-12

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 119 days early.

  • 202515/04/2026
  • 202402/04/2025
  • 202303/04/2024
  • 202231/03/2023
  • 202116/03/2022
  • 202007/04/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 2.01mMedianUSD 635.22kAverageUSD 7.52m
Net profit
This companyUSD 70.45kMedianUSD 12.57kAverageUSD 217.48k
Operating costs
This companyUSD 1.86mMedianUSD 586.83kAverageUSD 7.20m
Assets
This companyUSD 414.96kMedianUSD 367.33kAverageUSD 3.43m

Authorized Representatives

Adam Mikołaj Rybka – President of the Management Board

Manner of representation

Each member of the management board is independently authorised to make declarations of will concerning the company's property and non-property rights and to sign on behalf of the company.

Ownership

OwnerSharesShare valueStake
Adam Mikołaj Rybkaage 48
100$13,506.21100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2003-11-30.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,459
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$5,056
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,696

Competitors

Name
Bestpharmasp. z o.o.
Calfertsp. z o.o.
PK Components sp. z o.o.sp. k.
Nutri Partnerssp. z o.o.
Medicossp. z o.o.
PK Components Eu Ingredientssp. z o.o.
PUBE Globalsp. z o.o.
Symbiochemsp. z o.o.
Nomaksp. z o.o.
Kleemed Pharmaceuticals Polandsp. z o.o.

Change history

DateEvent
2019-08-09Address change
2002-04-12Address change
2002-04-12Share capital increase
2002-04-12Name change
2001-06-25Entered in the register

FAQ

Last updated: 2026-10-07